resolver

Herrmann-Rinke, C., Vöge, A., Hess, M., Göke, B. (1995). Regulation of glucagonlike
peptide-1 secretion from rat ileum by neurotransmitters and peptides. J
Endocrinol. 147, 25-31
Herzig, K.H., Schön, I., Tatemoto, K., Ohe, Y., Li, Y., Fölsch, U.R., Owyang, C.
(1996). Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in
the intestine. Proc Natl Acad Sci. 93, 7927-7932
Holst, J.J. (2004). On the physiology of GIP and GLP-1. Horm Metab Res. 36, 747-
754
Ivy, A.C., Oldberg, E. (1928). A hormone mechanism for gallbladder contraction and
evacuation. Am J Physiol. 86, 599-613
Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated
chronic hepatitis C virus infection. New England Journal of Medicine 2011;364:2405-
2416.
Jonderko, K., Krusiec-Swidergol, B., Mazur, W., Kasicka-Jonderko, A., Gonciarz,
M., Blonska-Fajfrowska, B., Gonciarz, Z. (2004). Effect of single-dose
administration of recombinant interferon-alpha2b on gastric myoelectrical activity in
patients with chronic hepatitis C. J Gastroenterol. 39, 1035-1044
Kasicka-Jonderko, A., Krusiec-Swidergol, B., Jonderko, K., Musialik, J., Gonciarz,
M., Blonska-Fajfrowska, B., Gonciarz, Z. (2009). Gastric myoelectrical activity in
patients with primary biliary cirrhosis. J Gastroenterol. 44, 346-352
Kau, A., Vermehren, J., Sarrazin, C. (2008). Treatment predictors of a sustained
virologic response in hepatitis B and C. J Hepatol. 49, 634-651
Kaukinen, P., Sillanpää, M., Kotenko, S., Lin, R., Hiscott, J., Melén, K., Julkunen, I.
(2006). Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell
cytokine/chemokine gene expression. Virol J. 3, 66
76